RB1 and cancer: This could be achieved through gene therapy, which could be ineffective, in theory, as a long-term cancer treatment, because the “rescued” Rb sufficient cancer stem cell would be eventually outcompeted by its own progeny—for example, cancer stem cells that would eliminate the gene-therapy-inserted normal functional RB1 allele.